Dr. Honig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Arcola Road
Collegeville, PA 19426
Summary
- Dr. Peter Honig is based in Collegeville, PA, specializing in Internal Medicine with a subspecialty in Clinical Pharmacology. He completed his residency in Internal Medicine at McGaw Medical Center of Northwestern University and furthered his training in Clinical Pharmacology at Uniformed Services University. Dr. Honig holds an MPH from Columbia University, where he also completed his medical degree. He has extensive experience in the pharmaceutical industry as a Senior Vice President at Pfizer, AstraZeneca, and Merck Research Labs, and serves as Managing Director at Blackstone Life Sciences. Previously, he worked as a Medical Officer at the FDA. Dr. Honig has several published works in notable journals such as Nature Reviews and Clinical Pharmacology and Therapeutics. His accolades include the FDA Alumni Award, the Gary Neil Innovation Award, and the Sol Katz Excellence in Teaching Award.
Education & Training
Uniformed Services University of the Health Sciences F. Edward Hebert School of MedicineClincal Pharmacology, 1990 - 1992
Columbia University School of Public HealthMPH, 1986 - 1989
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1982 - 1985
Columbia University Vagelos College of Physicians and SurgeonsClass of 1982
Awards, Honors, & Recognition
- FDA Alumni Award FDA, 2020
- Gary Neil Innovation in Drug Development Award ASCPT, 2016
- Sol Katz Excellence in Teaching Award Georgetown University Dept of Medicine, 1996
Publications & Presentations
PubMed
- 22 citationsApplication of Bayesian approaches in drug development: starting a virtuous cycle.Stephen J Ruberg, Francois Beckers, Rob Hemmings, Peter Honig, Telba Irony
Nature Reviews. Drug Discovery. 2023-03-01 - 6 citationsThe "Coming of Age" of Real-World Evidence in Drug Development and Regulation.Peter K Honig
Clinical Pharmacology and Therapeutics. 2022-01-01 - 17 citationsA Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem.Harry P. Selker, Theodora Cohen, Ralph B. D'Agostino, Willard H. Dere, S. Nassir Ghaemi
Clinical Pharmacology and Therapeutics. 2021-10-20
Press Mentions
Multidisciplinary Research Team Led by Tufts CTSI Proposes New Model for Clinical TrialsFebruary 10th, 2016
Industry Relationships
- Board of Directors, Drug Information Association2021 - Present
- Independent Director, Sesen Bio2021 - Present
- SVP, Pfizer2014 - 2021
- Board Member, Orexigen2010 - 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
